During the past decade, Cancer Research Consortium of West Michigan NCORP conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 98 clinical trials were completed, i.e. on average, 576.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 32 clinical trials were completed. i.e. 1066.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Research Consortium of West Michigan NCORP" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SCRI Development Innovations, LLC" with 34 trials sponsored, "Gynecologic Oncology Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "Academic and Community Cancer Research United" with 7 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research Consortium of West Michigan NCORP" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "Genentech, Inc." with 15 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Research Consortium of West Michigan NCORP" are "Breast Cancer" (14 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials), "Fallopian Tube Mucinous Adenocarcinoma" (7 trials), "Fallopian Tube Transitional Cell Carcinoma" (7 trials) and "Ovarian Endometrioid Adenocarcinoma" (7 trials). Many other conditions were trialed in "Cancer Research Consortium of West Michigan NCORP" in a lesser frequency.

Most popular intervention types in "Cancer Research Consortium of West Michigan NCORP" are "Drug" (129 trials), "Other" (84 trials), "Biological" (39 trials), "Procedure" (15 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Bevacizumab" (33 trials), "Quality-of-Life Assessment" (32 trials), "Paclitaxel" (29 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research Consortium of West Michigan NCORP" are 102 trials for "All" genders, 46 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Research Consortium of West Michigan NCORP". undefined are not yet recruiting, 4 are recruiting, 38 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 88 completed trials in Cancer Research Consortium of West Michigan NCORP, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research Consortium of West Michigan NCORP, 7 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".

Cancer Research Consortium of West Michigan NCORP has several departments that took part in Clinical trials: "CCOP - Grand Rapids Clinical Oncology Program" - 48 trials, "CCOP, Grand Rapids Clnical Oncology Program" - 2 trials